| Primary |
| Multiple Sclerosis |
77.8% |
| Product Used For Unknown Indication |
18.1% |
| Relapsing-remitting Multiple Sclerosis |
3.0% |
| Gastrooesophageal Reflux Disease |
0.1% |
| Depression |
0.1% |
| Gait Disturbance |
0.1% |
| Pain |
0.1% |
| Hypertension |
0.1% |
| Prophylaxis |
0.1% |
| Atrial Fibrillation |
0.1% |
| Bipolar Disorder |
0.0% |
| Fatigue |
0.0% |
| Muscle Spasms |
0.0% |
| Premedication |
0.0% |
| Neck Pain |
0.0% |
| Asthma |
0.0% |
| Constipation |
0.0% |
| Diabetes Mellitus |
0.0% |
| Insomnia |
0.0% |
| Flushing |
0.0% |
|
| Vomiting |
18.5% |
| Flushing |
17.4% |
| Nausea |
13.1% |
| Pruritus |
8.5% |
| Rash |
5.5% |
| Diarrhoea |
4.5% |
| Urticaria |
4.0% |
| Headache |
3.6% |
| Fatigue |
2.7% |
| Prescribed Underdose |
2.7% |
| Weight Decreased |
2.6% |
| Paraesthesia |
2.4% |
| Underdose |
2.3% |
| Multiple Sclerosis Relapse |
2.1% |
| Abdominal Pain Upper |
1.8% |
| Pain |
1.8% |
| Pyrexia |
1.8% |
| Memory Impairment |
1.6% |
| Gastrointestinal Disorder |
1.5% |
| Malaise |
1.5% |
|
| Secondary |
| Multiple Sclerosis |
80.3% |
| Product Used For Unknown Indication |
14.8% |
| Relapsing-remitting Multiple Sclerosis |
3.7% |
| Gastrooesophageal Reflux Disease |
0.2% |
| Depression |
0.2% |
| Pain |
0.1% |
| Premedication |
0.1% |
| Atrial Fibrillation |
0.1% |
| Hypertension |
0.1% |
| Muscle Spasms |
0.1% |
| Fatigue |
0.1% |
| Neck Pain |
0.1% |
| Bipolar Disorder |
0.1% |
| Asthma |
0.1% |
| Gait Disturbance |
0.1% |
| Constipation |
0.0% |
| Plasma Cell Myeloma |
0.0% |
| Prophylaxis |
0.0% |
| Anxiety |
0.0% |
| Cognitive Disorder |
0.0% |
|
| Vomiting |
24.5% |
| Flushing |
13.6% |
| Nausea |
12.6% |
| Pruritus |
7.7% |
| Prescribed Underdose |
7.3% |
| Underdose |
5.7% |
| Rash |
4.1% |
| Diarrhoea |
3.7% |
| Urticaria |
3.3% |
| Weight Decreased |
3.1% |
| Headache |
2.3% |
| Pyrexia |
2.0% |
| Paraesthesia |
1.7% |
| Fatigue |
1.4% |
| Weight Increased |
1.3% |
| Pain |
1.3% |
| Rhinorrhoea |
1.2% |
| Urinary Tract Infection |
1.2% |
| Abdominal Pain Upper |
1.1% |
| Abdominal Discomfort |
1.0% |
|
| Concomitant |
| Multiple Sclerosis |
78.1% |
| Product Used For Unknown Indication |
13.1% |
| Relapsing-remitting Multiple Sclerosis |
3.7% |
| Gait Disturbance |
1.8% |
| Premedication |
0.5% |
| Back Pain |
0.4% |
| Barrett's Oesophagus |
0.4% |
| Neuropathy Peripheral |
0.4% |
| Restless Legs Syndrome |
0.4% |
| Migraine |
0.3% |
| Back Disorder |
0.1% |
| Bladder Dysfunction |
0.1% |
| Contraception |
0.1% |
| Fibromyalgia |
0.1% |
| Gastrooesophageal Reflux Disease |
0.1% |
| Off Label Use |
0.1% |
| Pain |
0.1% |
| Swelling Face |
0.1% |
|
| Multiple Sclerosis Relapse |
12.7% |
| Multiple Sclerosis |
9.8% |
| Hypersensitivity |
8.8% |
| Influenza Like Illness |
7.8% |
| Memory Impairment |
6.9% |
| Adverse Drug Reaction |
5.9% |
| Pain |
5.9% |
| Hypertension |
3.9% |
| Mobility Decreased |
3.9% |
| Nystagmus |
3.9% |
| Urticaria |
3.9% |
| Anxiety |
2.9% |
| Drug Intolerance |
2.9% |
| Fall |
2.9% |
| Fatigue |
2.9% |
| Fear Of Injection |
2.9% |
| Gait Disturbance |
2.9% |
| Hot Flush |
2.9% |
| No Adverse Event |
2.9% |
| Off Label Use |
2.9% |
|
